Cargando…
Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
PURPOSE: TP53 mutation, one of the most frequent mutations in early‐stage lung adenocarcinoma (LUAD), triggers a series of alterations in the immune landscape, progression, and clinical outcome of early‐stage LUAD. Our study was designed to unravel the effects of TP53 mutation on the immunophenotype...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897963/ https://www.ncbi.nlm.nih.gov/pubmed/33314730 http://dx.doi.org/10.1002/cam4.3655 |